MedPath

Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children

Phase 1
Completed
Conditions
HIV Infections
Registration Number
NCT00000901
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

The purpose of this study is to see if it is safe and effective to give an anti-HIV drug combination of indinavir (IDV) plus stavudine (d4T) plus lamivudine (3TC) to HIV-infected children. IDV will be given either as a powder mixed into applesauce or as capsules given on an empty stomach.

Detailed Description

In this multicenter, open-label study patients receive a combined drug regimen of indinavir, stavudine, and lamivudine over 48 weeks. Patients are evaluated at Weeks 0, 2, 4, every 4 weeks until Week 24, and every 8 weeks thereafter until study completion. \[AS PER AMENDMENT 4/27/99: The study has been extended for an additional 48 weeks for a total of 96 weeks.\]

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (19)

UCSD Med Ctr / Pediatrics / Clinical Sciences

🇺🇸

La Jolla, California, United States

UCSF / Moffitt Hosp - Pediatric

🇺🇸

San Francisco, California, United States

Yale Univ Med School

🇺🇸

New Haven, Connecticut, United States

Univ of Florida Gainesville

🇺🇸

Gainesville, Florida, United States

Univ of Florida Health Science Ctr / Pediatrics

🇺🇸

Jacksonville, Florida, United States

Univ of Miami (Pediatric)

🇺🇸

Miami, Florida, United States

Children's Hosp of Boston

🇺🇸

Boston, Massachusetts, United States

North Shore Univ Hosp

🇺🇸

Great Neck, New York, United States

Schneider Children's Hosp

🇺🇸

New Hyde Park, New York, United States

Bellevue Hosp / New York Univ Med Ctr

🇺🇸

New York, New York, United States

Scroll for more (9 remaining)
UCSD Med Ctr / Pediatrics / Clinical Sciences
🇺🇸La Jolla, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.